by Don Gibbons | May 25, 2023
A recent Wall Street Journal article reminded me of the work of someone I came to know well while at the California Institute for Regenerative Medicine (CIRM): Jeanne Loring of the Scripps Research Institute. The article detailed a cell therapy for Parkinson’s Disease...
by Don Gibbons | May 4, 2023
For people like me working in the biological science sector, the annual DNA Day (every April 25th) is always a cause to raise a toast, but this year was special. It marked the 70th anniversary of the discovery of the double helix by Watson and Crick (and Franklin) and...
by Sara M. Nolte | Apr 18, 2023
One of the major limitations of using stem cell donors is the challenge of finding an adequate match, which is why I always get excited about therapies that use a patient’s own tissue. But why is the issue of a “match” such a big deal? You may have come across terms...
by Sara M. Nolte | Jan 19, 2023
While you all know me as a writer for Signals, I actually spend most of time working clinically. When wearing my health-care provider hat as a physician assistant in orthopaedics, I’m often asked about the use of stem cell therapy for the treatment of arthritis....
by Cal Strode | Jan 12, 2023
The Alliance for Regenerative Medicine (ARM) delivered its State of the Industry Briefing (#CGSOTI23) at Biotech Showcase, held January 9–11, 2023, in San Francisco, California. Tim Hunt, CEO, of the Alliance for Regenerative Medicine (ARM) kicked things off by...
by Stacey Johnson | Dec 23, 2022
Having written several “my favourite blog posts” over the years, I decided to turn this very important responsibility over to my communications colleagues at CCRM. I asked Cal Strode and Tannen Horber, who are both contributors and have bios on the site, to pick their...
Comments